Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic

Journal of Clinical Oncology

Volumn 19, Issue 8, 2001, Pages 2247-2253

  Martin, A M ^a   Blackwood, M A ^a   Antin Ozerkis, D ^a   Shih, H A ^a   Calzone, K ^a   Colligon, T A ^a   Seal, S ^a   Collins, N ^a   Stratton, M R ^a   Weber, B L ^a   Nathanson, K L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; EVALUATION; FAMILIAL CANCER; FEMALE; GEL ELECTROPHORESIS; GENE MUTATION; GENETIC SUSCEPTIBILITY; GERM LINE; HETERODUPLEX ANALYSIS; HUMAN; MULTIVARIATE ANALYSIS; ONCOGENE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0035871484     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.8.2247     Document Type: Article

References (26)

1. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families - The Breast Cancer Linkage Consortium
2. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families: Breast Cancer Linkage Consortium
3. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium
4. The contribution of germline BRCA1 and BRCA2 mutations in familial ovarian cancer: No evidence for other ovarian cancer-susceptibility genes
5. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer
6. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families
7. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes
8. High throughput fluorescence-based conformation-sensitive gel electrophoresis (FCSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families
9. Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient
10. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
11. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer
12. An Alumediated duplication in the BRCA1 gene: A new founder mutation?
13. Screening for genomic rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions
14. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations
15. Screening for genomic rearrangements in breast and ovarian cancer families identifies BRCA1 mutations previously missed by CSGE or sequencing
16. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
17. BRCA1 sequence analysis in women at high risk for susceptibility mutations: Risk factor analysis and implications for genetic testing
18. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women
19. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
20. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews
21. The importance of a family history of breast cancer in predicting the presence of a BRCA mutation
22. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
23. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene
24. De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation
25. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
26. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer